HomeNAVB • OTCMKTS
add
Navidea Biopharmaceuticals Inc
Previous close
$0.038
Day range
$0.038 - $0.040
Year range
$0.021 - $0.28
Market cap
3.58M USD
Avg Volume
66.46K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.13M | -4.16% |
Net income | -2.26M | 60.49% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.10M | 9.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.86M | -16.00% |
Total assets | 5.70M | -8.94% |
Total liabilities | 8.68M | -20.56% |
Total equity | -2.98M | — |
Shares outstanding | 99.99M | — |
Price to book | -1.25 | — |
Return on assets | -76.56% | — |
Return on capital | 912.23% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -2.26M | 60.49% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1983
Headquarters
Website
Employees
11